Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2000 1
2002 2
2004 1
2005 1
2008 1
2009 1
2011 2
2012 2
2013 2
2014 2
2016 1
2017 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Results by year
Filters applied: . Clear all
Page 1
Monoamine oxidases A and B gene polymorphisms in migraine patients.
Filic V, Vladic A, Stefulj J, Cicin-Sain L, Balija M, Sucic Z, Jernej B. Filic V, et al. Among authors: vladic a. J Neurol Sci. 2005 Feb 15;228(2):149-53. doi: 10.1016/j.jns.2004.11.045. Epub 2004 Dec 24. J Neurol Sci. 2005. PMID: 15694196
Recommendations for diagnosis and management of multiple sclerosis.
Kes VB, Zavoreo I, Serić V, Solter VV, Cesarik M, Hajnsek S, Pasić MB, Gabelić T, Silvio B, Butković SS, Lusić I, Grbelja LD, Vladić A, Bielen I, Antoncić I, Demarin V; Croatian Society for Neurovascular Disorders of Croatian Medical Association; Croatian Society of Neurology of Croatian Medical Association; Referral Center for Demyelinating Diseases of the CNS. Kes VB, et al. Among authors: vladic a. Acta Clin Croat. 2012 Mar;51(1):117-35. Acta Clin Croat. 2012. PMID: 22920014
Platelet serotonin measures in migraine.
Jernej B, Vladić A, Cicin-Sain L, Hranilović D, Banović M, Balija M, Bilić E, Sucić Z, Vukadin S, Grgicević D. Jernej B, et al. Among authors: vladic a. Headache. 2002 Jul-Aug;42(7):588-95. doi: 10.1046/j.1526-4610.2002.02145.x. Headache. 2002. PMID: 12482210
Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months.
De Mercanti S, Rolla S, Cucci A, Bardina V, Cocco E, Vladic A, Soldo-Butkovic S, Habek M, Adamec I, Horakova D, Annovazzi P, Novelli F, Durelli L, Clerico M. De Mercanti S, et al. Among authors: vladic a. Neurol Neuroimmunol Neuroinflamm. 2016 Jan 21;3(1):e194. doi: 10.1212/NXI.0000000000000194. eCollection 2016 Feb. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 26819963 Free PMC article.
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial.
Coles AJ, Fox E, Vladic A, Gazda SK, Brinar V, Selmaj KW, Skoromets A, Stolyarov I, Bass A, Sullivan H, Margolin DH, Lake SL, Moran S, Palmer J, Smith MS, Compston DA. Coles AJ, et al. Among authors: vladic a. Neurology. 2012 Apr 3;78(14):1069-78. doi: 10.1212/WNL.0b013e31824e8ee7. Epub 2012 Mar 21. Neurology. 2012. PMID: 22442431 Clinical Trial.
16 results